Sudarshan Pharma Industries Ltd. Hits Lower Circuit on BSE, 9 September 2026
- September 9, 2026
- Posted by: Harsh Piplani
- Category: News
On 9 September 2026 at 3:30 pm, Sudarshan Pharma Industries Ltd. (SUDARSHAN) hit the lower circuit on BSE at Rs 40.05, a 4.98% negative move from the previous close of Rs 42.15. The company’s market cap stood at Rs 1072.59 crore. The lower circuit price for the session was Rs 40.05.
The move was driven by selling pressure against the exchange-defined price band. The stock finished the session at its lower circuit level, which makes the day worth noting for short-term market participants.
Key Takeaways
- Sudarshan Pharma Industries Ltd. (SUDARSHAN) hit the lower circuit on BSE at Rs 40.05 on 9 September 2026.
- The session move was -4.98% against a previous close of Rs 42.15.
- Market capitalisation stood at Rs 1072.59 crore with a PE ratio of 42.7.
- No official company announcement or verified catalyst was confirmed at the time of writing.
- A price band is an exchange trading rule, not a view on the company or a recommendation.
Key Market Data
| Metric | Value |
|---|---|
| Stock | Sudarshan Pharma Industries Ltd. |
| Current Price / LTP | Rs 40.05 |
| Day Move | -4.98% |
| Previous Close | Rs 42.15 |
| Day Open | Rs 42.15 |
| Day High | Rs 42.5 |
| Day Low | Rs 40.05 |
| Lower Circuit Price | Rs 40.05 |
| Lower Circuit Limit | Rs 40.05 |
| Market Cap | Rs 1072.59 crore |
| Selected Exchange | BSE |
| PE Ratio | 42.7 |
All figures above are as of 9 September 2026 at 3:30 pm IST, sourced from Univest market data for the BSE listing. Only fields present in the source for this session are shown.
Price Action and Trading Activity
Sudarshan Pharma Industries Ltd. opened at Rs 42.15 on BSE, compared with a previous close of Rs 42.15. During the session, the stock traded between Rs 40.05 and Rs 42.5 before touching the lower circuit price of Rs 40.05.
The absolute day change was Rs 2.1, while the percentage move was -4.98%. The event figures are kept to a single exchange so the numbers stay comparable.
The selected exchange matters because price bands, day range, turnover, and previous-close values can differ across exchanges. This article uses BSE consistently for the event table and narrative. The stated lower circuit limit for the session was Rs 40.05, which is the level the price reached.
Why Sudarshan Pharma Industries Ltd. Hit Lower Circuit
Sudarshan Pharma Industries Ltd. hit the lower circuit after selling pressure pushed the stock to its exchange-defined price band. No official company announcement or verified external catalyst was confirmed at the time of writing, so the move should be read primarily through price action, turnover, and market sentiment.
Because no verified catalyst was available, this article does not attribute the move to earnings, corporate action, sector news, or market rumours. If a confirmed announcement becomes available later, it should be added as a separate update.
The stock stayed under pressure through the session and eventually reached the lower circuit level of Rs 40.05.
What the Lower Circuit Means
A lower circuit is the minimum price level a stock is allowed to reach during a trading session under the applicable exchange price band. For Sudarshan Pharma Industries Ltd., the captured lower circuit price was Rs 40.05 on 9 September 2026 at 3:30 pm.
The circuit mechanism is meant to slow extreme price movement and keep trading orderly. It is a market-structure fact, not a return forecast. In this article, the lower circuit explains what happened in the session and where the price band was reached.
Sudarshan Pharma Industries Ltd. Fundamentals and Valuation
Available market data gives a fuller picture than price action alone. For Sudarshan Pharma Industries Ltd., PE ratio was 42.7, PB ratio was 3.27, EPS was 0.99, ROE was 13.33% (FY25), ROCE was 14.42% (FY25) and dividend yield was 0%, on a market cap of Rs 1072.59 crore. These are available financial indicators and should not be read as a buy, sell, or hold view.
A PB ratio above 1 means the market price was above the reported book value per share. That premium can reflect growth expectations, asset quality, or simply thin trading in a smaller counter.
For investors tracking lower circuit moves, these metrics help separate the price event from the broader financial profile. A sharp one-day move can attract attention, but valuation and return ratios still need to be reviewed separately.
Peer and Sector Context
Sudarshan Pharma Industries Ltd. belongs to the Pharmaceuticals & Drugs industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.
| Peer Company | Market Cap | PE | PB | ROE |
|---|---|---|---|---|
| Ind-Swift Laboratories Ltd. | Rs 3377.59 crore | 58.92 | 2.26 | 24.68% |
| Hikal Ltd. | Rs 3037.51 crore | – | 2.55 | 7.41% |
| Dishman Carbogen Amcis Ltd. | Rs 2725.67 crore | 168.67 | 0.41 | 0.06% |
| Sakar Healthcare Ltd. | Rs 2576.21 crore | 71.37 | 7.7 | 6.48% |
| Windlas Biotech Ltd. | Rs 2369.86 crore | 35.66 | 4.61 | 12.52% |
A dash in the PE column means no PE ratio was carried for that company in the source data, which happens when reported earnings are negative or have not been refreshed. Those companies are left out of the average below rather than counted as zero.
Sudarshan Pharma Industries Ltd.’s PE ratio was 42.7, compared with an available peer/sector PE average of 66.92, calculated from the 4 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.
Technical and Ownership Snapshot
The technical snapshot adds context: RSI was 58.63, the 50-day moving average was 37.26 and the 200-day moving average was 31.95.
Worth flagging: the last traded price and the 50-day average point in different directions. Indicator values in the dataset can lag the live session, so they should be checked against a live chart before being relied on.
Shareholding details were not available in the latest market dataset, so no conclusion is drawn about promoter, institutional, or public-shareholder activity.
What Readers Should Know
The main confirmed fact is that Sudarshan Pharma Industries Ltd. hit the lower circuit on BSE at Rs 40.05 on 9 September 2026 at 3:30 pm, with a 4.98% day move.
The practical limitation after a lower-circuit session is execution. Sellers queue at the band with few buyers, so exiting at the quoted price may not be possible. The other limitation is that no official catalyst was confirmed at the time of writing.
Readers should treat lower circuit events as market updates, not standalone investment conclusions. The price band shows strong near-term interest, but follow-up analysis should consider business fundamentals, valuation, liquidity, risk, and confirmed company disclosures.
Frequently Asked Questions
Why did Sudarshan Pharma Industries Ltd. hit lower circuit on 9 September 2026?
The stock reached its lower price band after selling pressure during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.
What was SUDARSHAN share price on 9 September 2026?
The last traded price used in this article was Rs 40.05 on BSE. That price matched the lower circuit price captured for the event.
What was the lower circuit price for SUDARSHAN?
The lower circuit price was Rs 40.05. The stated exchange lower circuit limit was Rs 40.05. The event numbers in this article are aligned to BSE.
What is Sudarshan Pharma Industries Ltd.’s market cap and PE ratio?
Sudarshan Pharma Industries Ltd.’s market cap was Rs 1072.59 crore. PE ratio was 42.7.
Which exchange and data source were used?
The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 9 September 2026 at 3:30 pm.
Does hitting a lower circuit mean Sudarshan Pharma Industries Ltd. is a buy or a sell?
No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.
Can you buy or sell Sudarshan Pharma Industries Ltd. shares when the stock is at the lower circuit?
It is usually difficult. At the lower circuit, sell orders queue up with few buyers, so exiting at the quoted price may not be possible. Orders can stay unfilled until buying interest returns.
What happens the next trading session after a lower circuit?
There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether turnover holds up and whether the company files any disclosure explaining the move.
What is the lower circuit limit set at for Indian stocks?
Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Sudarshan Pharma Industries Ltd. the stated limit was Rs 40.05. For this session, Sudarshan Pharma Industries Ltd. moved 4.98%.
Footer Disclosure
Generated on 9 September 2026 at 3:30 pm using Univest market data. This article is for informational purposes only and does not constitute investment advice. SEBI RIA registration number INA000017639.
